Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by 1ottrunneron May 08, 2021 7:02am
170 Views
Post# 33159176

The great conspiracy of 2021

The great conspiracy of 2021If you've come to this message board looking for a bit of DD and some intelligent conversation, leave now.

There is no conspiracy.

RVV currently has 27 sites.  The trial offers $XXX.XX to be a participant and follow protocol.

You present with mild to moderate symptoms and you are offered the money to complete the course of treatment.

How many participants will complete the course of treatment?  90% maybe, more less...depends on the money they are offering.

Now lets say Bob decides to flush his Bucillamine rather than swallow it.  How is that qualified?

There are a lot of issues with an outpatient trial like this.  Even if Bucillamine is 100% effective it could fail due to participant error.

Is the participant going to the clinic every day for the course of treatment for observation?

The FDA and Pfizer have better things to do than get involved in this tiny trial.

Good luck guys, time to give up this handle to the next idiot and move on to another.  
<< Previous
Bullboard Posts
Next >>